HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Helge Karch Selected Research

Sorbitol (Yal)

12/2017Sorbitol-Fermenting Enterohemorrhagic Escherichia coli O157:H- Isolates from Czech Patients with Novel Plasmid Composition Not Previously Seen in German Isolates.
7/2007Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
3/2006Chromosomal dynamism in progeny of outbreak-related sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM.
3/2003Hemolytic-uremic syndrome associated with enterohemorrhagic Escherichia coli O26:H infection and consumption of unpasteurized cow's milk.
9/2002Identification and distribution of the enterohemorrhagic Escherichia coli factor for adherence (efa1) gene in sorbitol-fermenting Escherichia coli O157: H-.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Helge Karch Research Topics

Disease

25Hemolytic-Uremic Syndrome
12/2021 - 01/2002
25Infections
01/2020 - 01/2002
10Diarrhea
01/2018 - 01/2002
5Colitis
01/2018 - 09/2002
4Edema (Dropsy)
11/2019 - 06/2012
4Neoplasms (Cancer)
08/2012 - 03/2008
3Renal Insufficiency (Renal Failure)
01/2020 - 03/2006
3Pancreatic Neoplasms (Pancreatic Cancer)
08/2012 - 03/2008
2Nervous System Diseases (Neurological Disorders)
06/2013 - 06/2012
2Prion Diseases (Transmissible Spongiform Encephalopathies)
03/2011 - 11/2009
2Hemolysis
03/2009 - 03/2006
2Thrombosis (Thrombus)
02/2009 - 03/2006
1Superinfection
07/2018
1Enterocolitis
07/2018
1Fever (Fevers)
07/2018
1Mucositis
10/2016
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2016
1Bacterial Infections (Bacterial Infection)
10/2016
1Neutropenia
10/2016
1Inflammation (Inflammations)
03/2016
1Thrombotic Thrombocytopenic Purpura
10/2015
1Pathologic Constriction (Stenosis)
05/2015
1Urinary Tract Infections (Urinary Tract Infection)
01/2014
1Cerebrovascular Trauma
06/2013
1Neurologic Manifestations (Neurological Manifestations)
06/2013
1Ascites
08/2012
1Lymphatic Metastasis
08/2012
1Adenocarcinoma
08/2012
1Asymptomatic Infections
06/2012
1Chromosomal Instability (Chromosome Stability)
02/2011
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
01/2011
1Communicable Diseases (Infectious Diseases)
04/2010
1Colonic Neoplasms (Colon Cancer)
08/2009
1Acute Kidney Injury (Acute Renal Failure)
07/2007
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2006
1HELLP Syndrome
03/2006
1Vascular System Injuries
10/2005
1Enteritis
06/2005
1Experimental Autoimmune Neuritis
06/2005
1Complex Regional Pain Syndromes
05/2005
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2005
1Brain Diseases (Brain Disorder)
01/2005

Drug/Important Bio-Agent (IBA)

30Shiga Toxin (Shigella Toxin)IBA
12/2021 - 01/2002
13Virulence Factors (Pathogenicity Factors)IBA
01/2020 - 08/2005
9Shiga Toxins (Vero Toxin)IBA
01/2021 - 05/2002
5Sorbitol (Yal)FDA Link
12/2017 - 09/2002
5GlycosphingolipidsIBA
06/2013 - 03/2008
4Anti-Bacterial Agents (Antibiotics)IBA
07/2018 - 06/2012
3Immunoglobulin M (IgM)IBA
07/2018 - 05/2002
3AntibodiesIBA
07/2018 - 05/2002
3Proteins (Proteins, Gene)FDA Link
11/2010 - 06/2005
2LipidsIBA
11/2019 - 08/2009
2Shiga Toxin 2IBA
07/2018 - 03/2013
2globotriaosylceramide (globotriosylceramide)IBA
08/2012 - 08/2009
2CarbohydratesIBA
04/2010 - 03/2008
2Complement System Proteins (Complement)IBA
05/2009 - 03/2006
1phosphatidylethanolamineIBA
11/2019
1Immunoglobulin G (IgG)IBA
07/2018
1Ciprofloxacin (Cipro)FDA LinkGeneric
10/2016
1Colistin (Coly-Mycin)FDA Link
10/2016
1NAD (NADH)IBA
03/2016
1EicosanoidsIBA
03/2016
1FlagellinIBA
01/2016
1thiamine triphosphorate (TTP)IBA
10/2015
1Biological ProductsIBA
01/2013
1GlycoconjugatesIBA
08/2012
1Hemagglutinins (Hemagglutinin)IBA
08/2012
1globotetraosylceramideIBA
08/2012
1Prion ProteinsIBA
03/2011
1tellurous acid (tellurate)IBA
02/2011
1PrionsIBA
01/2011
1Complement Factor H (Factor H)IBA
05/2009
1nodularinIBA
05/2009
1cyanoginosin LR (microcystin LR)IBA
05/2009
1CalciumIBA
03/2009
1CeramidesIBA
03/2008
1spleen fibrinolytic proteinase (human) (SFP)IBA
02/2008
1von Willebrand FactorIBA
03/2006
1EnzymesIBA
03/2006
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
03/2006
1cytolethal distending toxinIBA
10/2005
1AutoantigensIBA
06/2005
1AntigensIBA
06/2005
1AutoantibodiesIBA
05/2005
1Shiga Toxin 1 (SLT-I)IBA
01/2005
1Metronidazole (Metric)FDA LinkGeneric
12/2003
1Amoxicillin (Wymox)FDA LinkGeneric
12/2003

Therapy/Procedure

4Therapeutics
01/2020 - 12/2003
1Plasmapheresis
07/2018
1Critical Care (Surgical Intensive Care)
07/2018
1Central Venous Catheters
10/2016
1Drug Therapy (Chemotherapy)
10/2016
1Antibiotic Prophylaxis
10/2016
1Denervation
05/2015
1Liver Transplantation
05/2015
1Adjuvant Chemotherapy
08/2009
1Transplantation
03/2006
1Kidney Transplantation
03/2006
1Renal Replacement Therapy (Therapies, Renal Replacement)
03/2006
1Debridement
12/2003